StemRIM (TSE:4599) Total Liabilities: 円238.98 Mil (As of Jan. 2026)


TSE:4599 StemRIM Inc TSE:4599
33 GF Score
Price 円301.00
! 2 Warning Signs
View Full Analysis

What is StemRIM Total Liabilities?

StemRIM TSE:4599 -2.90% 33 Total Liabilities is 円238.98 Mil as of Jan. 2026. GuruFocus rates TSE:4599 with a GF Score™ of 33/100. The stock has 2 warning signs investors should review.

StemRIM's Total Liabilities for the quarter that ended in Jan. 2026 was 円238.98 Mil.

StemRIM's quarterly Total Liabilities declined from Jan. 2025 (円211.58 Mil) to Jul. 2025 (円204.43 Mil) but then increased from Jul. 2025 (円204.43 Mil) to Jan. 2026 (円238.98 Mil).

StemRIM's annual Total Liabilities declined from Jul. 2023 (円336.02 Mil) to Jul. 2024 (円185.88 Mil) but then increased from Jul. 2024 (円185.88 Mil) to Jul. 2025 (円204.43 Mil).

StemRIM Total Liabilities Historical Data

* Premium members only.

The historical data trend for StemRIM's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

StemRIM Total Liabilities Chart

StemRIM Annual Data
Trend Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23 Jul24 Jul25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only 212.64 192.43 336.02 185.88 204.43

StemRIM Semi-Annual Data
Jul17 Jul18 Jul19 Jan20 Jul20 Jan21 Jul21 Jan22 Jul22 Jan23 Jul23 Jan24 Jul24 Jan25 Jul25 Jan26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 242.67 185.88 211.58 204.43 238.98
TSE:4599
33GF Score
StemRIM Inc TSE:4599
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

StemRIM Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

StemRIM's Total Liabilities for the fiscal year that ended in Jul. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=87.884+(0+116.546
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=204.43

Total Liabilities=Total Assets (A: Jul. 2025 )-Total Equity (A: Jul. 2025 )
=7518.659-7314.229
=204.43

StemRIM's Total Liabilities for the quarter that ended in Jan. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=123.667+(0+115.314
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=238.98

Total Liabilities=Total Assets (Q: Jan. 2026 )-Total Equity (Q: Jan. 2026 )
=6812.736-6573.755
=238.98

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of 円238.98 Mil mean?
StemRIM (TSE:4599) has a Total Liabilities of 円238.98 Mil as of Jan. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for StemRIM and its competitors.
Is StemRIM's Total Liabilities too high?
StemRIM's current Total Liabilities is 円238.98 Mil. Overall, StemRIM has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does StemRIM's Total Liabilities compare to VRTX and REGN?
StemRIM's Total Liabilities of 円238.98 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for StemRIM and its competitors. StemRIM's current Total Liabilities is 円238.98 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is StemRIM stock overvalued right now?
StemRIM (TSE:4599) has a current Total Liabilities of 円238.98 Mil. The current Total Liabilities is 円238.98 Mil. StemRIM's overall GF Score™ is 33/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For StemRIM (TSE:4599), the current Total Liabilities is 円238.98 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

StemRIM Business Description

Address 7-15 Ayato Bio Incubator 3rd floor, Ayato Asagi 7-chome, Prefecture Ibaraki City, Osaka, JPN, 567-0085
StemRIM Inc is a biotechnology company engaged in developing regeneration-guided medicines. The business activity of the group includes research, development, manufacture, and sales of pharmaceuticals and medical devices and products such as gene therapy that activate stem cells existing in the body and induce regeneration of damaged tissue.
33GF Score

Get the complete analysis for TSE:4599

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円301.00
Price